preval
pediatr
antimicrobi
stewardship
program
asp
increas
acut
care
facil
across
unit
state
past
sever
year
evid
base
use
inform
effect
stewardship
practic
expand
regulatori
interest
stewardship
program
increas
review
approach
establish
hospitalbas
pediatr
asp
adapt
report
standard
metric
broaden
reach
special
popul
expand
undertak
novel
stewardship
initi
implement
rapid
diagnost
continu
evolut
improv
antimicrobi
use
patient
outcom
preval
antimicrobi
stewardship
program
asp
target
pediatr
popul
increas
across
unit
state
although
number
newli
develop
program
increas
annual
mani
program
exist
year
prepar
undertak
new
intervent
track
report
novel
process
measur
clinic
outcom
implement
cuttingedg
diagnost
assay
expand
scope
new
popul
infecti
diseas
societi
america
societi
healthcar
epidemiolog
america
stewardship
guidelin
provid
valuabl
resourc
guid
clinician
interest
develop
implement
asp
furthermor
regulatori
effort
mandat
stewardship
activ
law
california
missouri
element
practic
requir
joint
commiss
accredit
increas
although
presid
obama
execut
order
requir
us
depart
health
human
servic
propos
new
regul
implement
asp
work
stall
make
presenc
formal
asp
acut
care
hospit
condit
particip
medicar
medicaid
servic
goal
review
supplement
exist
resourc
describ
current
state
pediatr
antimicrobi
stewardship
develop
countri
provid
suggest
asp
continu
evolv
extend
effort
new
direct
program
matur
expand
stewardship
program
develop
countri
critic
import
beyond
scope
review
presenc
asp
pediatr
facil
increas
rapidli
survey
freestand
children
hospit
reveal
formal
asp
wherea
addit
activ
implement
program
among
hospit
asp
physician
fulltim
equival
fte
support
stewardship
role
provid
median
fte
rang
fte
wherea
hospit
dedic
pharmacist
fte
median
fte
rang
fte
prospect
audit
feedback
formulari
restrict
clinic
guidelin
commonli
cite
program
strategi
use
although
asp
follow
model
use
dedic
clinic
pharmaci
infecti
diseas
id
specialist
least
pediatr
asp
use
altern
model
operation
program
integr
asp
activ
daili
function
servicebas
clinic
pharmacist
id
physician
weekend
holiday
sever
report
describ
asp
adult
institut
also
describ
model
includ
multipl
clinic
pharmacist
particip
asp
activ
furthermor
pediatr
model
daili
facetofac
handshak
stewardship
success
optim
antimicrobi
use
increas
number
id
consult
although
rigor
evalu
pediatr
asp
lack
studi
found
signific
posit
effect
formal
asp
inform
antimicrobi
stewardship
initi
systemat
review
smith
et
al
evalu
studi
involv
formal
pediatr
asp
studi
includ
antimicrobi
stewardship
activ
found
signific
reduct
antibiot
use
across
center
sever
includ
studi
also
identifi
signific
cost
save
result
asp
activ
other
identifi
improv
appropri
use
base
clinic
guidelin
recommend
gold
standard
ensur
sustain
effect
viabil
establish
asp
requir
formal
measur
involv
process
measur
eg
day
antimicrobi
therapi
length
antimicrobi
therapi
cost
data
clinic
outcom
eg
rate
clostridium
difficil
infect
cdi
length
hospit
stay
relat
readmiss
andor
balanc
measur
eg
ensur
use
narrowerspectrum
therapi
result
increas
treatmentfailur
rate
asp
measur
outcom
across
sever
categori
demonstr
effect
identifi
area
improv
process
measur
gener
focu
antibioticusag
data
calcul
patient
unit
hospit
level
either
defin
daili
dose
day
therapi
dot
dot
measur
use
commonli
unit
state
recommend
center
diseas
control
prevent
cdc
infecti
diseas
societi
america
dot
metric
repres
overal
total
number
antibiot
administ
total
number
day
exampl
patient
receiv
antibiot
day
dot
limit
dot
account
spectrum
activ
use
narrowspectrum
multidrug
regimen
increas
dot
metric
use
singl
verybroadspectrum
agent
similarli
dot
measur
alon
captur
desir
therapi
chang
deescal
singl
broadspectrum
agent
target
one
limit
address
track
consumpt
specif
target
agent
complementari
metric
antibiot
spectrum
index
develop
measur
pattern
antibiot
select
deescal
address
limit
dot
numer
normal
hospit
censu
gener
use
patientday
denomin
patientday
calcul
basi
hospit
censu
given
time
day
eg
midnight
altern
cdc
creat
electron
tool
call
antibioticus
option
encourag
acut
care
facil
report
antibioticusag
data
nation
healthcar
safeti
network
use
numer
dot
denomin
day
present
encourag
riskadjust
interfacil
intrafacil
benchmark
antibiot
use
dayspres
metric
calcul
number
patient
present
portion
day
calendar
month
specif
locat
exampl
patient
admit
pediatr
intens
care
unit
picu
monday
afternoon
remain
tuesday
wednesday
transfer
gener
pediatr
ward
wednesday
discharg
home
later
day
would
contribut
day
toward
picu
dayspres
denomin
day
toward
pediatricward
denomin
note
subtl
differ
patient
day
day
present
patient
day
often
less
hospit
length
stay
day
exampl
patient
present
midnight
day
wherea
dayspres
denomin
enabl
captur
entir
time
hospit
time
differ
locat
day
present
picu
plu
day
present
medic
ward
exampl
regard
dayspres
measur
enabl
nuanc
assess
benchmark
antibiot
use
occur
within
hospit
length
therapi
lot
defin
total
number
calendar
day
patient
receiv
antibiot
use
also
exampl
dotlot
ratio
provid
measur
mean
number
antibiot
receiv
patient
per
day
evalu
metric
hospit
overal
accord
clinic
unit
eg
medic
picu
servic
line
eg
pulmonari
hematologyoncolog
antibiot
class
eg
macrolid
carbapenem
rout
eg
oral
intraven
inform
program
seek
identifi
area
work
last
hospit
compar
one
anoth
asp
hospit
particip
pediatr
health
inform
system
databas
collabor
share
antibioticus
data
benchmark
one
anoth
beyond
util
metric
asp
consid
monitor
process
measur
time
optim
therapi
patient
invas
infect
percent
agreement
asp
recommend
percent
peripher
insert
central
cathet
potenti
avoid
time
convers
intraven
oral
administr
highli
bioavail
antibiot
data
stratifi
accord
clinic
unit
servic
line
suggest
area
ongo
improv
asp
monitor
proactiv
compensatori
chang
antibioticprescrib
behavior
basi
activ
ie
balanc
measur
increas
piperacillintazobactam
use
carbapenem
access
restrict
period
reevalu
whether
program
strategi
updat
ad
new
formulari
restrict
although
process
measur
import
asp
monitor
might
compel
prescrib
clinician
therefor
resourc
appli
evalu
clinic
outcom
report
clinician
program
track
clinic
data
includ
mortal
rate
hospit
length
stay
readmiss
especi
focus
patient
confirm
infect
eg
bloodstream
infect
program
especi
consid
track
cdi
rate
concret
measur
outcom
associ
increas
lo
cost
death
among
children
asp
effort
found
reduc
incid
cdi
track
cdi
rate
among
children
without
difficulti
howev
given
variou
diagnost
test
avail
preval
c
difficil
colon
among
young
children
potenti
relev
clinic
outcom
includ
antibiot
appropri
incid
antibioticresist
pathogen
asp
might
need
commun
even
improv
clinic
outcom
observ
lack
worsen
clinic
outcom
eg
find
reduc
durat
therapi
patient
communityacquir
pneumonia
day
increas
hospit
readmiss
might
meaning
also
must
acknowledg
assign
causal
chang
clinic
outcom
challeng
certain
event
death
rel
rare
children
mani
asp
focus
use
specif
target
antibiot
either
preprescript
author
postprescript
audit
feedback
focus
instead
specif
infecti
syndrom
might
meaning
clinician
invest
directli
patient
outcom
might
less
concern
specif
antibioticus
metric
exampl
messag
want
improv
diagnosi
treatment
children
hospitalacquir
pneumonia
might
foster
clinician
engag
want
reduc
unnecessari
vancomycin
use
number
clinic
relev
syndrom
consid
target
includ
communityacquir
pneumonia
skin
softtissu
infect
append
bone
joint
infect
prevent
surgicalsit
infect
establish
program
consid
expand
effort
includ
subpopul
account
small
percentag
overal
popul
receiv
disproportion
high
percentag
antibiot
stewardship
activ
success
warrant
subpopul
includ
children
malign
solid
organ
hematopoiet
stem
cell
transplant
recipi
neonat
children
emerg
depart
children
medic
complex
condit
cystic
fibrosi
undergo
surgic
procedur
reason
start
point
new
effort
develop
evidencebas
local
guidelin
includ
input
multidisciplinari
team
best
achiev
inperson
meet
asp
member
might
find
integr
effort
exist
clinic
specialti
workgroup
meet
good
entri
point
process
outcom
measur
relev
specif
servic
target
thu
inclus
physician
pharmacist
champion
individu
servic
assist
develop
relev
stewardship
metric
critic
exampl
develop
guidelin
picu
involv
reduc
durat
therapi
children
ventilatorassoci
pneumonia
asp
might
believ
emerg
resist
pathogen
import
outcom
wherea
picu
faculti
might
think
reintub
rate
meaning
novel
popul
asp
target
defin
underli
diseas
process
facet
care
exampl
asp
focu
children
discharg
undergo
outpati
parenter
antimicrobi
therapi
opat
overus
opat
expos
patient
complic
catheterassoci
infect
thrombosi
opat
avoid
children
favor
oral
therapi
infect
osteomyel
similarli
investig
remov
unnecessari
allergi
label
repres
opportun
asp
direct
patient
toward
firstlin
gener
narrowspectrum
agent
asp
contribut
understand
optim
antibiot
dose
pharmacokinet
period
updat
local
standard
around
antibiot
use
eg
consid
use
vancomycin
area
curveminimum
inhibitori
concentr
ratio
use
extendedinfus
electron
health
record
order
set
modifi
decreas
durat
antibiot
common
infect
use
automat
antibiot
order
discontinu
brief
period
empir
use
seem
safe
effect
reduc
broadspectrum
antibiot
use
hospit
larg
referr
base
even
consid
use
local
asp
resourc
provid
stewardship
remot
commun
hospit
last
pediatr
antibiot
use
occur
ambulatori
set
asp
expand
provid
resourc
guidanc
patient
set
clinic
microbiolog
laboratori
role
stewardship
activ
limit
develop
guidelin
appropri
specimen
test
antibiogram
creation
select
report
blind
antibioticsuscept
test
result
howev
recent
explos
new
technolog
enabl
earlier
identif
pathogen
detect
select
antibioticresist
gene
bring
clinic
microbiolog
laboratori
forefront
asp
activ
asp
leader
work
microbiologist
provid
clinician
educ
specif
diagnost
implement
tabl
summar
target
turnaround
time
clinic
outcom
associ
commonli
use
rapid
diagnost
test
clinic
microbiolog
laboratori
tabl
use
mani
diagnost
test
associ
decreas
time
effect
therapi
shorter
hospit
length
stay
reduc
hospit
cost
reduc
mortal
rate
howev
optim
clinic
outcom
novel
diagnost
ideal
implement
clinic
decis
support
guid
result
interpret
appropri
antibiot
prescrib
decis
support
come
mani
form
electron
comment
within
microbiolog
result
report
realtim
audit
feedback
asp
import
caveat
rapid
molecular
diagnost
use
detect
resist
determin
among
gramposit
organ
predict
methicillin
vancomycin
resist
reliabl
lead
antibiot
escal
deescal
contrast
gramneg
bacteria
contain
plethora
resist
mechan
includ
porin
mutat
efflux
pump
current
avail
molecular
platform
identifi
specif
use
rule
drug
resist
escal
therapi
rule
resist
unlik
affect
decis
deescal
antibiot
infect
last
diagnost
test
overus
use
incorrectli
order
c
difficil
test
infant
program
steward
microbiolog
diagnost
test
potenti
decreas
unnecessari
antibiot
use
improv
patient
outcom
much
antibiot
use
hospit
children
empir
use
rapid
diagnost
identifi
specif
viral
infect
rsv
hsv
help
reduc
unnecessari
antibiot
use
procalcitonin
pct
diagnost
test
use
increasingli
biomark
distinguish
bacteri
infect
infecti
inflammatori
condit
although
studi
date
adult
literatur
util
pct
evalu
infant
fever
pneumonia
sever
bacteri
infect
grow
sever
studi
adult
found
pct
test
combin
treatment
algorithm
develop
asp
patient
expos
significantli
shorter
antibiot
cours
increas
advers
clinic
outcom
pct
test
may
similarli
enhanc
judici
antibiot
prescrib
children
deserv
studi
sustain
stewardship
requir
adopt
across
provid
disciplin
beyond
id
physician
clinic
pharmacist
requir
ongo
educ
joint
commiss
develop
new
antimicrobi
stewardship
standard
requir
hospit
educ
antibiot
prescrib
appropri
antibiot
use
use
exist
cdc
tool
local
develop
materi
engag
hospit
pharmacist
member
asp
way
extend
asp
activ
across
hospit
furthermor
nurs
increasingli
identifi
critic
partner
stewardship
activ
accord
cdc
core
element
antibiot
stewardship
nurs
encourag
review
medic
part
routin
duti
prompt
discuss
antibiot
treatment
indic
durat
patient
readi
transit
oral
therapi
hospitalist
likewis
vital
partner
stewardship
effort
disciplin
expand
rapidli
often
involv
qualiti
improv
effort
effici
use
healthcar
resourc
previou
multisit
hospitalist
collabor
success
enhanc
antimicrobi
document
access
local
guidelin
implement
antibiot
timeout
vermont
oxford
network
newborn
improv
collabor
qualiti
interdisciplinari
associ
focus
antimicrobi
stewardship
organ
goal
integr
formal
stewardship
train
activ
medic
educ
onlin
curricula
lectur
medic
student
rotat
stewardship
resid
fellow
also
essenti
ensur
adequ
prepar
futur
gener
antibiot
prescrib
past
sever
year
increas
number
acut
care
facil
implement
pediatr
asp
growth
come
opportun
engag
research
examin
understudi
aspect
stewardship
role
behavior
chang
intervent
implement
stewardship
novel
patient
care
set
use
target
assess
stewardship
outcom
optim
stewardship
intervent
although
aim
stewardship
intervent
prompt
behavior
chang
antibiot
prescrib
stewardship
intervent
lack
assess
behavior
determin
prescrib
practic
produc
sustain
chang
studi
examin
behavior
determin
identifi
prescrib
etiquett
includ
adher
social
norm
influenc
medic
hierarchi
factor
underli
certain
prescrib
behavior
addit
studi
identifi
belief
drive
antibioticprescrib
practic
barrier
practic
stewardship
need
direct
develop
sustain
stewardship
intervent
addit
given
varieti
patient
care
set
dispar
resourc
avail
clinician
across
set
clear
onesizefitsal
approach
address
stewardship
need
larger
medic
commun
effect
much
pediatr
research
perform
date
assess
stewardship
program
acut
care
set
primarili
within
freestand
children
hospit
need
expand
antimicrobi
stewardship
across
healthcar
spectrum
need
research
pediatr
longterm
care
facil
becom
evid
likewis
commun
hospit
might
regular
access
specialist
tradit
compris
asp
id
physician
clinic
pharmacist
although
strategi
tailor
composit
asp
commun
hospit
set
suggest
studi
valid
efficaci
approach
includ
role
telemedicin
lack
tertiari
care
pediatr
inpati
set
work
also
need
understand
pattern
antivir
antifung
use
curb
overus
given
potenti
toxic
high
cost
electron
medic
record
system
continu
evolv
abil
use
advanc
decis
support
optim
antibiot
prescrib
real
time
individu
patient
also
becom
increasingli
widespread
aim
stewardship
optim
clinic
outcom
minim
unintend
consequ
antibiot
use
improv
antibiot
prescrib
follow
studi
need
evalu
effect
stewardship
intervent
clinic
outcom
howev
studi
evalu
asp
focus
mostli
process
outcom
decreas
antibiot
use
decreas
cost
data
effect
stewardship
intervent
clinic
outcom
gener
limit
specif
diseas
syndrom
although
econom
metric
help
obtain
support
hospit
administr
metric
fail
provid
adequ
assess
given
intervent
abil
accomplish
aim
stewardship
formal
econom
evalu
cost
avoid
difficult
studi
evalu
clinic
outcom
eg
clinic
cure
failur
resist
rate
rate
cdi
advers
drug
reaction
interact
length
stay
need
aid
determin
optim
intervent
highlight
import
stewardship
program
clinician
